Cargando…

Remodeling of Ion Channel Expression in Patients with Chronic Atrial Fibrillation and Mitral Valvular Heart Disease

BACKGROUND/AIMS: Underlying cardiac pathology and atrial fibrillation (AF) affect the molecular remodeling of ion channels in the atria. Changes in the expression of these molecules have not been demonstrated in Korean patients with mitral valvular heart disease. Thus, the purpose of this study was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oh, Seil, Kim, Ki-Bong, Ahn, Hyuk, Cho, Hyun-Ju, Choi, Yun-Shik
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Association of Internal Medicine 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997966/ https://www.ncbi.nlm.nih.gov/pubmed/21179275 http://dx.doi.org/10.3904/kjim.2010.25.4.377

Ejemplares similares

Intracellular lactate signaling cascade in atrial remodeling of mitral valvular patients with atrial fibrillation
por: Xu, Jing, et al.
Publicado: (2013)

Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart Disease
por: Moon, Inki, et al.
Publicado: (2019)

Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
por: Samaras, Athanasios, et al.
Publicado: (2021)

Stroke Prevention in Atrial Fibrillation and Valvular Heart Disease
por: Ahmad, Saad, et al.
Publicado: (2016)

Metabolomic and Proteomic Analyses of Persistent Valvular Atrial Fibrillation and Non-Valvular Atrial Fibrillation
por: Hu, Bo, et al.
Publicado: (2021)

Prevalence of Non-valvular Atrial Fibrillation Based on Geographical Distribution and Socioeconomic Status in the Entire Korean Population
por: Lee, So-Ryoung, et al.
Publicado: (2018)

Novel fibro-inflammation markers in assessing left atrial remodeling in non-valvular atrial fibrillation
por: Sonmez, Osman, et al.
Publicado: (2014)

Relationship between valvular structure and biochemical indices of non-valvular atrial fibrillation and senile degenerative valvular heart disease
por: Chen, Jian-Qin, et al.
Publicado: (2023)

Atrial Fibrillation as a Prognostic Indicator in Medium to Large‐Sized Dogs with Myxomatous Mitral Valvular Degeneration and Congestive Heart Failure
por: Jung, S.W., et al.
Publicado: (2016)

Echocardiographic Assessments of Left Atrial Strain and Volume in Healthy Patients and Patients With Mitral Valvular Heart Disease by Tissue Doppler Imaging and 3-Dimensional Echocardiography
por: Shin, Mi-Seung, et al.
Publicado: (2009)

Leukocyte TRP channel gene expressions in patients with non-valvular atrial fibrillation
por: Düzen, Irfan V., et al.
Publicado: (2017)

Prognostic Value of Left Atrial Function in Dogs with Chronic Mitral Valvular Heart Disease
por: Nakamura, K., et al.
Publicado: (2014)

Mitochondrial DNA 4977bp Deletion Mutation in Peripheral Blood Reflects Atrial Remodeling in Patients with Non-Valvular Atrial Fibrillation
por: Lee, Jihei Sara, et al.
Publicado: (2015)

Histological and Biochemical Comparisons between Right Atrium and Left Atrium in Patients with Mitral Valvular Atrial Fibrillation
por: Park, Jae Hyung, et al.
Publicado: (2014)

Left Atrial Structural Remodelling in Non-Valvular Atrial Fibrillation: What Have We Learnt from CMR?
por: Floria, Mariana, et al.
Publicado: (2020)

Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in octogenarian patients with non-valvular atrial fibrillation
por: Kim, Hyue Mee, et al.
Publicado: (2019)

Newer Anticoagulants for Non-Valvular Atrial Fibrillation
por: Harburger, Joseph M., et al.
Publicado: (2012)

Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions
por: Di Biase, Luigi
Publicado: (2016)

Expression Profiles of Circular RNA in Human Atrial Fibrillation With Valvular Heart Diseases
por: Zhu, Xiyu, et al.
Publicado: (2020)

Quality of Anticoagulation and Treatment Satisfaction in Patients with Non-Valvular Atrial Fibrillation Treated with Vitamin K Antagonist: Result from the KORean Atrial Fibrillation Investigation II
por: Oh, Seil, et al.
Publicado: (2018)

Atrial Electrophysiological Remodeling and Fibrillation in Heart Failure
por: Pandit, Sandeep V., et al.
Publicado: (2016)

Computational fluid dynamics modelling of left valvular heart diseases during atrial fibrillation
por: Scarsoglio, Stefania, et al.
Publicado: (2016)

Novel oral Anticoagulants in Non-Valvular Atrial Fibrillation
por: da Silva, Rose M.F.L.
Publicado: (2014)

Comparison of Prolonged Atrial Electromechanical Delays with Different Definitions in the Discrimination of Patients with Non-Valvular Paroxysmal Atrial Fibrillation
por: Lee, Dong Hyun, et al.
Publicado: (2015)

Mitral stenosis and atrial fibrillation
por: Westermann, Dirk, et al.
Publicado: (2020)

Functional mitral regurgitation: predictor for atrial substrate remodeling and poor ablation outcome in paroxysmal atrial fibrillation
por: Qiao, Yu, et al.
Publicado: (2016)

Impact of age on thromboembolic events in patients with non‐valvular atrial fibrillation
por: Kim, Yun Gi, et al.
Publicado: (2019)

Antiplatelet Therapy Combinations and Thrombogenicity in Patients with Non-Valvular Atrial Fibrillation
por: Park, Yongwhi, et al.
Publicado: (2017)

Clinical characteristics and 12-month outcomes of patients with valvular and non-valvular atrial fibrillation in Kenya
por: Temu, Tecla M., et al.
Publicado: (2017)

Intraoperative loading dose of amiodarone for prophylaxis against atrial fibrillation after valvular heart surgery
por: Amr, Yasser Mohamed, et al.
Publicado: (2010)

Effectiveness and safety of rivaroxaban vs. warfarin in patients with non‐valvular atrial fibrillation and heart failure
por: Martinez, Brandon K., et al.
Publicado: (2018)

Effectiveness and safety of oral anticoagulants in older adults with non-valvular atrial fibrillation and heart failure
por: Amin, Alpesh, et al.
Publicado: (2019)

Influence of atrial ultrastructural remodeling on its early mechanical transport following surgery for atrial fibrillation and mitral insufficiency
por: Kopjar, T, et al.
Publicado: (2013)

Reverse Atrial Remodeling and Resolution of Mitral Regurgitation after Rhythm Control in Atrial Fibrillation: A Case Report
por: Al Qahtani, Shaya Yaanallah, et al.
Publicado: (2019)

Association of inflammation indices with left atrial thrombus in patients with valvular atrial fibrillation
por: Zhou, You, et al.
Publicado: (2023)

Non-valvular atrial fibrillation: impact of apixaban on patient outcomes
por: Ioannou, Adam, et al.
Publicado: (2017)

Causes of death of patients with non-valvular atrial fibrillation in Asians
por: Krittayaphong, Rungroj, et al.
Publicado: (2023)

Thromboembolism and Major Bleeding in Patients with Atrial Fibrillation and EHRA Type 2 Valvular Heart Disease: The Jordan Atrial Fibrillation (JoFib) Study
por: Al-Najar, Mahasen, et al.
Publicado: (2023)

Persistent or permanent atrial fibrillation is associated with severe cardioembolic stroke in patients with non-valvular atrial fibrillation
por: Hagii, Joji, et al.
Publicado: (2021)

Oral anticoagulants and concurrent rifampin administration in tuberculosis patients with non-valvular atrial fibrillation
por: Hwang, Ki Won, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tmvdaabbalice5o1tani2jem71